2011
DOI: 10.1016/j.jpedsurg.2011.03.031
|View full text |Cite
|
Sign up to set email alerts
|

Safety of ketorolac in surgical neonates and infants 0 to 3 months old

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
24
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(26 citation statements)
references
References 12 publications
1
24
0
1
Order By: Relevance
“…Bowel was moved in maximum patients in both groups, most patients passed their urine from the beginning of the operation. There are scarcity of published materials on postoperative ketorolac use in neonates, those available are mainly on children and those available on neonates express the similar findings as in this study 25,27 . According to Taddio et al (2000) both acetaminophen and ketorolac are safe drugs regarding cardiac activity, respiratory function and temperature regulation.…”
Section: Discussionsupporting
confidence: 75%
See 2 more Smart Citations
“…Bowel was moved in maximum patients in both groups, most patients passed their urine from the beginning of the operation. There are scarcity of published materials on postoperative ketorolac use in neonates, those available are mainly on children and those available on neonates express the similar findings as in this study 25,27 . According to Taddio et al (2000) both acetaminophen and ketorolac are safe drugs regarding cardiac activity, respiratory function and temperature regulation.…”
Section: Discussionsupporting
confidence: 75%
“…It is generally well tolerated, but the risk for bleeding and renal dysfunction must always be taken into consideration 24 . However, minimal safety data exist regarding the use of ketorolac in neonates 25 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The studies also failed to show a significant difference in the rate of adverse events between patients treated with ketorolac versus placebo although Aldrink et al (25) found an increased association between bleeding events in patients who received ketorolac and the lack of previous exposure to enteral feeds. Although the association was not statistically significant, this finding may be of clinical significance in a patient population that is likely to be on parenteral nutrition without the potentially protective effects of enteral feeds on the gastrointestinal system.…”
Section: Ketorolacmentioning
confidence: 98%
“…The most frequently used drugs are opioids and non-steroidal anti-inflammatory drugs such as fentanyl, morphine, buprenorphine, paracetamol and ketorolac [7][8][9][10] . Recognized side effects of opioids are hypotension, respiratory depression, prolonged ileus, ventilator dependence and depression of the immune system in a dose-dependent response [11,12] , whereas ketorolac may decrease platelet aggregation, increase bleeding events and cause renal insufficiency [9,13] . Thus, studies examining non-pharmacological strategies or ways to combine with other treatments or balance these treatments for neonatal patients to achieve optimal pain relief with less prolonged exposure are needed [4,14].…”
Section: Introductionmentioning
confidence: 99%